Summary of findings: monoclonal antibody KB001‐A vs placebo
Inflammatory markers · children (12 or over) and adults with cystic fibrosis and lung infection
1 finding from 1 review
- Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 196 participantsVery low